Arcus Biosciences, Inc. (RCUS)

21.53 -3.61 (-14.36%) USD  |  NYSE  |  Dec 12, 16:00
21.51 -0.02 (-0.09%) After-Hours: 20:00
More

Arcus Biosciences Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Actinium Pharmaceuticals, Inc. --
Merck & Co., Inc. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade